GT Medical Technologies

GT Medical Technologies is a medical device company that offers innovative medical solutions for brain tumor patients.

GT Medical Technologies operates in health based in Tokyo, Japan.

Profile

GT Medical Technologies was founded by a dedicated team of brain tumor specialists to address unmet needs in brain tumor treatment. The company is committed to improving the lives of patients with brain tumors through innovative solutions that elevate the standard of care. GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors. By delivering radiation directly from within—placed into the surgical cavity at the time of tumor removal—GammaTile provides immediate, localized treatment. This approach targets remaining cancer cells when they are at their lowest levels to help prevent regrowth, while minimizing radiation exposure to healthy brain tissue.(1) Since its full market launch in the United States in March 2020, GammaTile has been adopted by more than 100 leading centers, underscoring its growing acceptance in both academic and community healthcare settings. For more information, visit gammatile.com.

Within the health space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in Tokyo, Japan.

Directory data places it at the Plug and Play portfolio startup stage.

Website: www.gtmedtech.com